Stock Update (NYSE:MRK): U.S. FDA approves Merck insomnia drug

[Reuters] – The U.S. Food and Drug Administration said on Wednesday it has approved a new insomnia drug made by Merck & Co.. The drug, to be called Belsomra, is the first in . . . → Read More: Stock Update (NYSE:MRK): U.S. FDA approves Merck insomnia drug Similar Articles: Company Update (NYSE:MRK): Merck Announces Third-Quarter 2014 Dividend Merck & Co Inc (NYSE:MRK) – Merck Animal Health Announces FDA Approval of BRAVECTO™ (fluralaner) Stock Update (NYSE:LLY): U.S. FDA approves Eli Lilly drug for stomach cancer